Rovi Pharmaceuticals Laboratories

This early-stage study tested a new version of the schizophrenia medication risperidone given as a shot every three months. Researchers wanted to see how the drug moves through the body and if it is safe. 58 adults with stable schizophrenia who already take oral risperidone recei…

This study looked at how well Risperidone ISM works in real-world settings for people with schizophrenia who were hospitalized after a relapse. Researchers tracked 275 patients over 56 days to see if their symptoms and daily functioning improved. The goal was to understand the dr…